Detalhe da pesquisa
1.
IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia.
J Clin Invest
; 132(17)2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36047494